Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$9.99 - $18.27 $92,527 - $169,216
9,262 Added 40.96%
31,877 $400,000
Q4 2022

Feb 14, 2023

BUY
$14.16 - $24.02 $320,228 - $543,212
22,615 New
22,615 $337,000
Q2 2022

Aug 12, 2022

SELL
$13.31 - $34.88 $186,340 - $488,320
-14,000 Closed
0 $0
Q4 2021

Feb 01, 2022

BUY
$26.0 - $37.03 $364,000 - $518,420
14,000 New
14,000 $430,000
Q3 2021

Nov 12, 2021

SELL
$29.75 - $37.99 $416,500 - $531,860
-14,000 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$32.81 - $45.1 $459,340 - $631,400
14,000 New
14,000 $596,000

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $786M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.